NEW YORK (GenomeWeb) – Precision for Medicine said today that it has acquired Houston-based ApoCell, which specializes in the identification and analysis of biomarkers in both tissue and liquid biopsy.

Specific terms of the deal were not disclosed.

The acquisition adds ApoCell's ApoStream liquid biopsy technology and its expertise in tissue genomic profiling to Precision's existing suite of specialty laboratory and biomarker informatics services, which include cell-based assays and various immune monitoring technologies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.